» Articles » PMID: 25523434

Prevalence and Risk Factors for Diabetes and Diabetic Retinopathy: Results from the Nigeria National Blindness and Visual Impairment Survey

Overview
Publisher Biomed Central
Specialty Public Health
Date 2014 Dec 20
PMID 25523434
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In Nigeria, urbanisation and increasing life expectancy are likely to increase the incidence of non-communicable diseases. As the epidemic of diabetes matures, visual loss from diabetic retinopathy (DR) will increase unless mechanisms for early detection and treatment improve, and health systems respond to the growing burden of non-communicable diseases.

Methods: A nationally-representative population-based sample of 13,591 participants aged ≥40 years selected by multistage-stratified-cluster-random-sampling with probability-proportional-to-size procedures were examined in 305 clusters in Nigeria between January 2005 to June 2007. All were asked about history of diabetes and underwent basic eye examination. Visual acuity (VA) was measured using logMAR E-chart. Participants with VA<6/12 and/or DR detected underwent detailed eye examination including dilated retinal examination and retinal photography. Systematic sampling of 1-in-7 gave a subsample (n=1759) examined in detail regardless of VA; and had random blood glucose (RBG) testing. Images were graded by Moorfields Eye Hospital Reading Centre. Participants were defined as having diabetes if they were previously diagnosed or RBG>11.1mmol/l or had DR. Data in the subsample were used to estimate the prevalence and to analyse risk factors for diabetes and DR using multivariable logistic regression. Additional information on the types of DR was obtained from participants not in the subsample.

Results: In the subsample, 164 participants were excluded due to missing data; and 1,595 analysed. 52/1,595 had diabetes, a prevalence of 3.3% (95%CI 2.5-4.3%); and 25/52(48%) did not know. Media opacity in 8/52 precluded retinal examination. 9/44(20.5%) had DR. Higher prevalence of diabetes was associated with urban residence (Odds ratio [OR]1.87) and overweight/obesity (OR3.02/4.43 respectively). Although not statistically significant, DR was associated with hypertension (OR3.49) and RBG>15.0mmol/L (OR8.10). Persons with diabetes had 3 times greater odds of blindness. Of 11,832 other participants in the study sample, 175(1.5%) had history of diabetes; 28 had DR. Types of DR (total=37) included 10.8% proliferative, 51.4% macular oedema.

Conclusion: The age-adjusted prevalence of diabetes in Nigeria was 3.25% (95%CI 2.50-4.30) and over 10% of people with diabetes aged ≥40 years had sight-threatening-DR. These data will enable the development of better public health strategies for the control of diabetes and planning services for DR to prevent vision loss.

Citing Articles

Incidence of diabetic retinopathy and predictors among adult patients with diabetes in central and southern Ethiopia: a multicentre retrospective cohort study.

Yakob T, Abraham A, Yakob B, Jaldo M BMJ Open. 2025; 15(1):e090916.

PMID: 39842931 PMC: 11784131. DOI: 10.1136/bmjopen-2024-090916.


Diabetes in China: epidemiology, pathophysiology and multi-omics.

Jia W, Chan J, Wong T, Fisher E Nat Metab. 2025; 7(1):16-34.

PMID: 39809974 DOI: 10.1038/s42255-024-01190-w.


Insights Into Sociodemographic Influences on Type 2 Diabetes Care and Opportunities for Digital Health Promotion in Port Harcourt, Nigeria: Quantitative Study.

Arueyingho O, Aprioku J, Marshall P, OKane A JMIR Diabetes. 2024; 9:e56756.

PMID: 39167439 PMC: 11375378. DOI: 10.2196/56756.


The Need to Appear Healthy: Concealment of Chronic Illness, Privacy, and Self-Sufficiency Among Chronically Ill Older Nigerians.

Mahmoud K, Baker T, Esiaka D, Balogun S Innov Aging. 2024; 8(4):igad141.

PMID: 38628821 PMC: 11020260. DOI: 10.1093/geroni/igad141.


Diabetes Mellitus as a risk factor for stroke among Nigerians: A systematic review and meta-analysis.

Azeez T, Durotoluwa I, Makanjuola A Int J Cardiol Cardiovasc Risk Prev. 2023; 18:200189.

PMID: 37250184 PMC: 10220413. DOI: 10.1016/j.ijcrp.2023.200189.


References
1.
Mohamed Q, Gillies M, Wong T . Management of diabetic retinopathy: a systematic review. JAMA. 2007; 298(8):902-16. DOI: 10.1001/jama.298.8.902. View

2.
Amoah A, Owusu S, Adjei S . Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res Clin Pract. 2002; 56(3):197-205. DOI: 10.1016/s0168-8227(01)00374-6. View

3.
Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya J, Gautier J . Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab. 2002; 27(6):628-34. View

4.
Wang F, Liang Y, Zhang F, Wang J, Wei W, Tao Q . Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology. 2009; 116(3):461-7. DOI: 10.1016/j.ophtha.2008.10.003. View

5.
Krishnaiah S, Das T, Nirmalan P, Shamanna B, Nutheti R, Rao G . Risk factors for diabetic retinopathy: Findings from The Andhra Pradesh Eye Disease Study. Clin Ophthalmol. 2009; 1(4):475-82. PMC: 2704526. View